Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) Germany
Research
Date range: 1 April 2021 - 31 March 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
9 | 0.87 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 8 | 0.74 |
Chemistry | 1 | 0.13 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.04 | 0.04 | 0.23 | 0.45 | 0.06 |
Collaboration
Date range: 1 April 2021 - 31 March 2022
International vs. domestic collaboration by Share
- 60.58% Domestic
- 39.42% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) by Share (25 total)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Hannover Medical School (MHH)
(2.13)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Fraunhofer Society
(1.06)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Helmholtz Association of German Research Centres
(1.05)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and The German Center for Lung Research (DZL)
(1.02)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and CAPNETZ Stiftung
(0.98)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Leibniz University Hannover (LUH)
(0.98)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and University of Göttingen
(0.57)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and RWTH Aachen University (RWTH Aachen)
(0.42)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and 8sens.biognostic GmbH
(0.42)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Free University of Berlin (FU Berlin)
(0.41)
Top 10 international collaborators with Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) by Share (34 total)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Yale University
(2.15)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and UCL
(0.56)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Technical University of Denmark (DTU)
(0.45)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and National Institutes of Health (NIH)
(0.36)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Institute of Health Carlos III (ISCIII)
(0.36)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Leiden University
(0.34)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and European Commission (EC)
(0.34)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Harvard University
(0.26)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Tel Aviv University (TAU)
(0.25)
-
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Sohag University
(0.21)
Relationships
Partner Institutions
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.